Widespread oral and oropharyngeal mucosal oedema induced by ecstasy (MDMA): A case for concern

British Journal of Oral and Maxillofacial Surgery

Volumn 45, Issue 6, 2007, Pages 496-498

  Ahmed, M ^a   Islam, S ^a   Hoffman, G R ^b  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Adverse reaction; Ecstasy; Oedema; Oral mucosa

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CHLORHEXIDINE; CHLORPHENIRAMINE; ERYTHROMYCIN; HYDROCORTISONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; MALE; MOUTH MUCOSA; MUCOSAL DISEASE; OROPHARYNX; PATIENT ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; TREATMENT OUTCOME;

ADOLESCENT; ALCOHOL DRINKING; AMPHETAMINE-RELATED DISORDERS; EDEMA; HUMANS; MALE; MOUTH DISEASES; MOUTH MUCOSA; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE;

EID: 34547561983     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2007.04.002     Document Type: Article

References (10)

1. United Nations Office for Drug Crime Prevention. World Drug Report (2001), Oxford University Press, New York
2. In: Aust R., Sharp C., and Goulden C. (Eds). Prevalence of Drug Use: key findings from the 2001/2 British Crime Survey. Home Office Research Findings 182 (2002), Home Office, London
3. Pacifici R., Zuccaro P., Farre M., et al. Cell mediated immune response in MDMA users after repeated dose administration: status in controlled versus noncontrolled settings. Ann NY Acad Sci 965 (2002) 421-433
4. Tucker G.T., Lennard M.S., Ellis S.W., et al. The demethylenation of methylenedioxymethamphetamine (ecstasy) by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 47 (1994) 1151-1156
5. Zhu B.T. Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 3 (2002) 321-349
6. de la Torre R., Farre M., Ortuno J., et al. Non-linear pharmacokinetics of MDMA (ecstasy) in humans. Br J Clin Pharmacol 49 (2000) 104-109
7. Peroutka S.J., Newman H., and Harris H. Subjective effects of 3,4 methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1 (1988) 273-277
8. Duxbury A.J. Ecstasy-dental implications. Br Dent J 175 (1993) 38
9. Redfearn P.J., Agrawal N., and Mair L.H. An association between the regular use of 3,4-methylenedioxymethamphetamine (ecstasy) and excessive wear of the teeth. Addiction 93 (1998) 745-748
10. Henry J.A., Fallon J.K., Kicman A.T., Hutt A.J., Cowan D.A., and Forsling M. Low-dose MDMA ("ecstasy") induces vasopressin secretion. Lancet 351 (1998) 1784